Experimental Pill Doubles Pancreatic Cancer Survival Rates
An experimental daily pill has shown promising results in clinical trials, doubling the survival time for patients with pancreatic cancer. This breakthrough offers new hope for treating the deadly disease.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Excellent (100/100)Sources
Experimental pill promises new hope for deadly pancreatic cancer - AP News
Experimental pill promises new hope for deadly pancreatic cancer AP News
Read full article →Daily pill doubles survival time for pancreatic cancer patients
The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.
Read full article →Daily pill can double survival time for world’s deadliest cancer, trial shows
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest breakthroughs in decades. Currently, there are few treatments for pancreatic cancer, and most do little or nothing to help. For decades, scientists have worked relentlessly trying to find clever solutions for a fo...
By Andrew Gregory Health editor in Chicago
Read full article →Experimental pill promises new hope for deadly pancreatic cancer
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.
By The Associated Press
Read full article →Experimental pill promises new hope for deadly pancreatic cancer
Those taking daraxonrasib lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients.
Read full article →Experimental pancreatic cancer pill doubles survival chances, boosts quality of life - The Straits Times
Experimental pancreatic cancer pill doubles survival chances, boosts quality of life The Straits Times
Read full article →Revolution Medicines reports Phase 3 win in pancreatic cancer
Read full article →Pill offers hope in treating deadly pancreatic cancer
Pill users lived an average of 13.2 months versus 6.7 months for those undergoing chemotherapy
By Peter Weber, The Week US
Read full article →Experimental pill offers breakthrough hope in pancreatic cancer fight
An experimental drug for advanced pancreatic cancer significantly extended survival in a major clinical trial, offering fresh hope for improved treatment against one of the deadlie...
Read full article →Daily pill doubles survival time for pancreatic cancer patients
A pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game-changer.
By Abubakar Ibrahim
Read full article →
